Precision Optics Corporation, Inc. reports recurring business developments in advanced optical instruments for the medical and defense/aerospace industries. The company designs, develops and manufactures custom optical medical devices, endoscopes, endocouplers and related optical assemblies, with news frequently covering single-use endoscopy programs and customer production orders.
Updates for POCI also include product-development work for aerospace and defense applications, including small-diameter borescope systems used in jet-engine inspection. Company announcements commonly address fiscal-period operating results, conference calls, customer program activity, backlog and pipeline commentary, and capital-structure actions involving its Nasdaq-listed common stock.
Precision Optics (Nasdaq: POCI), a leading designer and manufacturer of advanced optical instruments for medical and defense/aerospace industries, has announced its participation in the virtual Lytham Partners Fall 2025 Investor Conference on September 30, 2025.
The company will deliver a webcast presentation at 10:15 a.m. ET and conduct one-on-one meetings with investors throughout the event. Interested parties can access the webcast through the conference website, with replay available after the event.
Precision Optics (NASDAQ: POCI) reported Q4 and FY 2025 financial results, with record Q4 revenue of $6.2 million, up 48% year-over-year. FY 2025 revenue was $19.1 million, with production revenue growing 34% to $14.2 million. The company reported a net loss of $(5.8) million for FY 2025.
For FY 2026, POCI projects revenue exceeding $25 million (31% growth) and expects gross margins to improve to approximately 30% from 18% in FY 2025. The company anticipates Adjusted EBITDA of $0.5 million in FY 2026, compared to $(3.7) million in FY 2025.
Additionally, POCI appointed Joseph Traut as new Chief Operating Officer effective October 1, 2025, granting him inducement stock options for 60,000 shares.
Precision Optics (Nasdaq: POCI), a leading designer and manufacturer of advanced optical instruments for medical and defense/aerospace industries, has scheduled its fourth quarter and fiscal year 2025 financial results conference call for September 29, 2025, at 5:00 p.m. ET.
The company will release its financial results and file its 10-K after market close on the same day. Investors can join via phone at (844) 735-3662 or (412) 317-5705, or through a live webcast. A replay will be available for seven days following the call.
Precision Optics (Nasdaq: POCI), a designer and manufacturer of advanced optical instruments for medical and defense/aerospace industries, will participate in the Lytham Partners 2025 Consumer & Technology Investor Summit on August 19, 2025.
The company's virtual presentation is scheduled for 9:30 a.m. ET and will be accessible through the conference website. A replay of the webcast will be available following the presentation.
Precision Optics Corporation (NASDAQ: POCI), a specialized manufacturer of advanced optical instruments for medical and defense/aerospace sectors, has announced its participation in the upcoming Lytham Partners Spring 2025 Investor Conference on May 29, 2025.
The company will deliver a webcast presentation at 10:15 a.m. ET and conduct one-on-one meetings with investors throughout the virtual event. Interested participants can access the webcast through the conference website or arrange individual meetings with management through Lytham Partners.
Precision Optics Corporation (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, has scheduled a conference call to discuss its third quarter fiscal year 2025 financial results on Thursday, May 15, 2025, at 5:00 p.m. ET.
The company will release its financial results and file its 10-Q after market close on the same day. Interested parties can join the call by dialing (844) 735-3662 or (412) 317-5705, or access the live webcast at the provided link. A replay will be available for seven days.
Precision Optics (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, has announced its participation in the Planet MicroCap Showcase: VEGAS 2025.
The presentation is scheduled for Wednesday, April 23, 2025, at 4:00 p.m. Pacific Time (7:00 p.m. Eastern Time) at Track 3 – Chablis in the Paris Hotel & Casino, Las Vegas. Dr. Joe Forkey, CEO, will lead the presentation and conduct a Q&A session.
The company will also hold one-on-one meetings with interested parties on April 24, 2025. Investors can access the live presentation through the provided webcast link and schedule 1x1 meetings through Planet MicroCap representatives or the company's investor relations team.
Precision Optics (NASDAQ: POCI) has signed a Main Purchase Agreement with a leading aerospace company, solidifying their commercial partnership that began in September 2023. The agreement showcases significant growth with:
- $3.1 million in new orders received during the current calendar year
- Total program backlog of $6.6 million to be delivered over the next 12 months
- Nearly $4 million per year in minimum purchase commitments through calendar 2026
To meet increased demand, POCI has doubled its clean room production line capacity. The partnership leverages Precision Optics' proprietary manufacturing technology for commercial aerospace applications.